Evidence map›Paper›PMID 30226124›Full record

ArticleInfection control and hospital epidemiology2018

Effectiveness of ultraviolet disinfection in reducing hospital-acquired Clostridium difficile and vancomycin-resistant Enterococcus on a bone marrow transplant unit.

Jennifer Brite, Tracy McMillen, Elizabeth Robilotti, Janet Sun, Hoi Yan Chow, Frederic Stell, Susan K Seo, Donna McKenna, Janet Eagan, Marisa Montecalvo and 3 more

Abstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Ultraviolet-C Light Evaluation as Adjunct Disinfection to Remove Multidrug-Resistant Organisms.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Trial
  5. Article
  6. Article
  7. Article
  8. Minimizing the risk ofAntimicrobial stewardship & healthcare epidemiology : ASHE · 2023
    Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jennifer Brite1Infection Control,Department of Medicine,Memorial Sloan Kettering Cancer Center,New York,New York.
Tracy McMillen1Infection Control,Department of Medicine,Memorial Sloan Kettering Cancer Center,New York,New York.
Elizabeth Robilotti1Infection Control,Department of Medicine,Memorial Sloan Kettering Cancer Center,New York,New York.
Janet Sun1Infection Control,Department of Medicine,Memorial Sloan Kettering Cancer Center,New York,New York.
Hoi Yan Chow1Infection Control,Department of Medicine,Memorial Sloan Kettering Cancer Center,New York,New York.
Frederic Stell4Environmental Services,Memorial Sloan Kettering Cancer Center,New York,New York.
Susan K Seo2Infectious Disease Service,Memorial Sloan Kettering Cancer Center,New York,New York.
Donna McKenna6Westchester Medical Center,Valhalla,New York.
Janet Eagan1Infection Control,Department of Medicine,Memorial Sloan Kettering Cancer Center,New York,New York.
Marisa Montecalvo5Department of Medicine,New York Medical College,Valhalla,New York.
Donald Chen5Department of Medicine,New York Medical College,Valhalla,New York.
Kent Sepkowitz2Infectious Disease Service,Memorial Sloan Kettering Cancer Center,New York,New York.
Mini Kamboj1Infection Control,Department of Medicine,Memorial Sloan Kettering Cancer Center,New York,New York.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Novel Risk Factors For Vancomycin Resistant Enterococci In Persons With CancerK23AI083880 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI KAMBOJ, MINI · 2010 to 2014
$652k
NCI NIH HHS P30 CA008748NIAID NIH HHS K23 AI083880
6 · The paper itself

Abstract

objectiveTo determine the effectiveness of ultraviolet (UV) environmental disinfection system on rates of hospital-acquired vancomycin-resistant enterococcus (VRE) and Clostridium difficile.

designUsing active surveillance and an interrupted time-series design, hospital-acquired acquisition of VRE and C. difficile on a bone marrow transplant (BMT) unit were examined before and after implementation of terminal disinfection with UV on all rooms regardless of isolation status of patients. The main outcomes were hospital-based acquisition measured through (1) active surveillance: admission, weekly, and discharge screening for VRE and toxigenic C. difficile (TCD) and (2) clinical surveillance: incidence of VRE and CDI on the unit.

settingBone marrow transplant unit at a tertiary-care cancer center.ParticipantsStem cell transplant (SCT) recipients.InterventionTerminal disinfection of all rooms with UV regardless of isolation status of patients.

resultsDuring the 20-month study period, 579 patients had 704 admissions to the BMT unit, and 2,160 surveillance tests were performed. No change in level or trend in the incidence of VRE (trend incidence rate ratio [IRR], 0.96; 95% confidence interval [CI], 0.81-1.14; level IRR, 1.34; 95% CI, 0.37-1.18) or C. difficile (trend IRR, 1.08; 95% CI, 0.89-1.31; level IRR, 0.51; 95% CI, 0.13-2.11) was observed after the intervention.

conclusionsUtilization of UV disinfection to supplement routine terminal cleaning of rooms was not effective in reducing hospital-acquired VRE and C. difficile among SCT recipients.

Indexed as

Ultraviolet RaysBone Marrow TransplantationClostridioides difficileClostridium InfectionsColony Count, MicrobialCross InfectionDisinfectionGram-Positive Bacterial InfectionsHumansInterrupted Time Series AnalysisNew YorkPatients' RoomsVancomycin-Resistant Enterococci

Identifiers

PMID30226124
PMCPMC8524758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.